KORU Medical Systems to Participate in Canaccord Genuity’s 41st Annual Growth Conference

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced that the Company will participate in Canaccord Genuity’s 41st Annual Growth Conference.

KORU Medical Systems’ management is scheduled to present at Canaccord Genuity’s 41st Annual Growth Conference on Thursday, August 12, 2021 at 3:00 PM EDT. Interested parties can access the live and archived webcast on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.50
-0.52 (-0.21%)
AAPL  266.43
+7.60 (2.94%)
AMD  258.12
+3.05 (1.20%)
BAC  54.32
+0.97 (1.82%)
GOOG  334.47
+3.89 (1.18%)
META  671.58
+9.09 (1.37%)
MSFT  411.22
+18.11 (4.61%)
NVDA  198.87
+2.36 (1.20%)
ORCL  169.81
+6.81 (4.18%)
TSLA  391.95
+27.75 (7.62%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.